Meta?Analysis of Intracranial Hemorrhage in Acute Coronary Syndromes: Incidence, Predictors, and Clinical Outcomes

30.06.20151428
Little is known about the incidence, predictors, or outcomes of intracranial hemorrhage (ICH) in patients with non–ST?segment elevation acute coronary syndromes (NSTE ACS).

Peritoneal Dialysis for Chronic Congestive Heart Failure

29.06.20151430
Maladaptive responses between a failing heart and the kidneys ultimately lead to permanent chronic kidney disease, referred to as cardiorenal syndrome type 2.

American Society of Nuclear Cardiology offers RSC members free memberships

26.06.20152409
ANSC would like to partner with the Russian Society of Cardiology. As part of the outreach program, ASNC and GE Healthcare are working to distribute some complimentary International memberships in Russia for the rest of 2015.

Younger, older HF patients require different disease management

25.06.20151357
Although younger patients represent one third of all HF hospitalizations, they are poorly represented in clinical trials, and more research is needed to learn which strategies improve readmission and mortality in this population, according to researchers.

Bridging anticoagulation unnecessary in patients with AF who stop warfarin before procedure

24.06.20151411
Forgoing bridging anticoagulation offered similar results as bridging with heparin to prevent thromboembolism perioperatively in patients with atrial fibrillation who temporarily halted warfarin treatment before undergoing a procedure, according to findings published in The New England Journal of Medicine.

FDA approves cangrelor for reduction of thrombotic events in patients with CAD needing PCI

23.06.20151511
The FDA announced that it has approved cangrelor, an intravenous P2Y12 receptor antagonist, for the reduction of thrombotic events in adult patients with CAD undergoing PCI.

Comparison of carvedilol and metoprolol for preventing contrast-induced nephropathy after coronary angiography

22.06.20151530
The aim of this study was to analyze and compare the effects of carvedilol and metoprolol on the development of contrast–induced nephropathy (CIN) in patients undergoing coronary angiography.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.